HemoCue Logo
X

Select your destination

This is Hemocue's global website and may contain information on products not released in all markets.
For information on products and services in your local market, please proceed to your local Hemocue website.

Continue to Hemocue.com

Meet Our Owners

HemoCue is a part of the Radiometer Group since April 2013. The acquisition enables both HemoCue and Radiometer to accelerate company growth and innovation in point-of-care patient testing.

Founded in 1935 and headquartered in Copenhagen, Denmark, Radiometer was a pioneer in blood gas testing, introducing the world’s first blood gas analyzer in 1954 in the fight against childhood polio epidemic.

Radiometer HQ

Today, Radiometer offers solutions for blood gas analysis, transcutaneous monitoringimmunoassay testing for cardiac coagulation, infection and pregnancy markers and point-of-care management. By providing fast and accurate acute diagnostic results, Radiometer products help healthcare professionals make immediate and well-informed decisions to improve patient care and optimize patient flow in all acute care settings, i.e. intensive care units (ICU), emergency departments (ED) and operating rooms (OR).

For more information please visit www.radiometer.com

Ownership

Radiometer is part of Danaher Corporation's (NYSE:DHR) life sciences and diagnostics platform, offering a broad range of analyzers, consumables, software and services used to diagnose diseases and make treatment decisions in pathology labs, hospitals and other critical care settings.

Other life sciences and diagnostics companies owned by Danaher Corporation are HemoCue (part of the Radiometer Group), Beckman Coulter, Leica Microsystems, Leica Biosystems, Molecular Devices, AB Sciex and PALL Corporation.

Cookies are used on this site

Use of cookies